William G Breen

12PUBLICATIONS
75CO-AUTHORS
Immunogenetics (incl. genetic immunology)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)NanomedicineComputational imaging
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Sep 17, 2026
Ivosidenib in predominantly recurrent IDH1-mutant glioma: A single-institution experience.

|Jul 01, 2026
Defining rapid early progression in glioblastoma-A volumetric approach.

|May 20, 2026
Cost-effectiveness of vorasidenib in treatment of isocitrate dehydrogenase-mutated low-grade glioma.

|Jun 28, 2025
Final report on North Central Cancer Treatment Group N0877 (alliance): A phase II randomized, placebo-controlled trial of chemoradiotherapy with or without dasatinib for glioblastoma.

William G Breen, Jesse G Dixon, S Keith Anderson

|Apr 17, 2025
Improved Survival and Prognostication in Melanoma Patients With Brain Metastases: An Update of the Melanoma Graded Prognostic Assessment.

Paul W Sperduto, Kathryn E Marqueen, Enoch Chang

|Apr 17, 2024
Integration of Telemedicine Consultation Into a Tertiary Radiation Oncology Department: Predictors of Use, Treatment Yield, and Effects on Patient Population.

Yasamin Sharifzadeh, William G Breen, William S Harmsen

Pageof 2

Frequent Collaborators

3 joint publications

Mark Waddle

2 joint publications

Paul W Sperduto

2 joint publications

Toshimichi Nakano

2 joint publications

Tony J C Wang